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 Philip Morris International: A New Year’s resolution 
 
In January 2018, Philip Morris International (PMI) placed ads in UK newspapers explaining 
that their New Year’s resolution was ‘to stop selling cigarettes in the UK’, see Figure 1.1 To 
help achieve this goal, the PMI ads refer to four commitments for 2018: 
 
1) Launch a website and campaign to provide smokers with information on quitting and on 
alternatives to cigarettes; 
2) Offer to support Local Authority cessation services where smoking rates are highest; 
3) Seek Government approval to insert, directly into our cigarette packs, information on 
quitting and on switching; 
4) Expand the availability of new, alternative products in the UK. 
 
Figure 1: PMI advert in the UK 
 
While the second commitment is contrary to Article 5.3 obligations of the WHO FCTC,2 and 
the third prohibited by the Standardised Packaging of Tobacco Products Regulations 2015,3 
the latter, at least, could be amended by the UK government. The relevant text, ‘No insert or 
additional material may be attached to or included with the packaging of a unit packet or 
container packet of cigarettes’, could be revised with the addition of ‘unless specified by 
Government (e.g. to educate consumers about the benefits of quitting or to promote self-
efficacy to quit)’. What is apparent for all four commitments, however, is the potential that 
each brings for PMI to promote their alternative, non-combustible, nicotine containing 
products. 
There may be myriad reasons why PMI chose the UK as a testing ground for this type 
of campaign, but the evolving nicotine market is likely reason enough. With respect to 
combustible products, the outlook is bleak for PMI. Smoking prevalence is at a record low in 
the UK, with cigarette sales falling year-on-year and volume recovery unrealistic.4 In 
addition, PMI’s share of the cigarette market fell to 8.1% in 2016 and their most profitable 
brand (Marlboro), which constitutes most of this market share, has declined steadily since at 
least 2012.4 Furthermore, the long-term decline of the premium cigarette sector, where 
Marlboro is positioned, looks set to continue now that standardised packaging has been fully 
implemented, as was found in Australia after standardised packaging was introduced in 
2012.5 That the UK is one of the largest global markets for rolling tobacco6 provides little 
solace for PMI, given that the three other leading tobacco companies (Imperial Brands, Japan 
Tobacco International, British American Tobacco) have a stranglehold on this sector in the 
UK.   
More promising for PMI is the broad acceptance of alternative nicotine-containing 
products in the UK, where the government has endorsed e-cigarettes for smoking cessation.7 
PMI’s IQOS is currently the only heat-not-burn product on sale in the UK, having been 
available since November 2016. As such, PMI is well-placed to seize what may be a highly 
profitable opportunity if the UK government allows them to follow through on their four New 
Year’s commitments. Encouraging consumers to use IQOS – whether online, via cessation 
services or through product packaging – would give PMI a strong competitive advantage in 
the UK, while simultaneously bolstering their credentials as responsible corporate citizens. In 
this context, their 'vision' appears driven by a financial imperative rather than a genuine 
desire to protect public health. If PMI were serious about stopping selling cigarettes in the 
UK they could have provided a clear timeline for doing so. If they are serious about 
eliminating smoking worldwide,8 then why do they continue to promote their combustible 
products9 and litigate against evidence-based tobacco control policy. It may be a different 
year, a different product and a different tactic, but the goal appears to remain the same.  
Concomitant with these developments in the UK, PMI have been promoting IQOS via 
the packaging of some of their cigarette brands in Canada (see Figure 2). PMI have a greater 
market share of cigarettes in Canada than in the UK (33.5% in 2012),10 but Canada is equally 
hostile towards combustible tobacco and there has been a long-term decline in smoking 
prevalence and sales (and the premium sector). This looks likely to continue as standardised 
packaging and a more permissive regulatory framework for e-cigarettes are in the final 
legislative stages. These promotional packs in Canada suggest that PMI would use inserts in 
the UK to promote IQOS.  
Figure 2: PMI packs in Canada promoting IQOS 
 Irrespective of PMI’s true intent with their New Year’s resolution, their support for 
the inclusion of pack inserts promoting cessation may be a late Christmas present for public 
health. It is puzzling that in 17 years no country has followed the lead of Canada by requiring 
tobacco companies to include inserts aimed at promoting cessation in cigarette packs, while 
approximately 100 countries followed their lead by requiring pictorial health warnings on 
cigarette packs. After all, the health communication literature suggests that the most effective 
way to change behaviour is to combine fear messages (as generally communicated by the on-
pack health warnings) alongside messages promoting self- and response-efficacy (as used on 
inserts in Canada). In addition, the nascent literature is supportive of pack inserts promoting 
cessation,11-14 as is Article 11 of the WHO FCTC.15 There are also no logistical challenges to 
their inclusion, given that tobacco companies have used pack inserts to promote their 
products across the world since the late 19th century.16 With the largest global multinational 
tobacco company supportive of inserts promoting cessation, then so long as these are 
designed by public health what obstacles are in the way of regulators introducing this 
measure in the UK and elsewhere?  
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